glp-1 adherence Higher Rates of Persistence and in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study) | Diabetes Therapy Higher out-of-pocket costs for GLP-1

So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance

Module 3 covers movement, nutrition, and behavior science: protein targets (1.62.2 g/kg/day), resistance training, time-restricted eating, circadian alignment, and behavioral tools

Available at St-Onge MP, Tasali E

doi:10.3389/fpubh.2022.996179 8

Inject the medication slowly and at a 90-degree angle to help minimize discomfort